149 related articles for article (PubMed ID: 38726026)
21. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
22. A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer.
Chen JY; Tong YH; Chen HY; Yang YB; Deng XY; Shao GL
Front Oncol; 2023; 13():1066352. PubMed ID: 36969034
[TBL] [Abstract][Full Text] [Related]
23. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.
Chen XZ; Zhang WH; Chen HN; Liu JP; He D; Liu Y; Liu K; Chen XL; Mo XM; Zhou ZG; Hu JK
Oncotarget; 2016 Apr; 7(17):23647-57. PubMed ID: 27027339
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of lymphovascular and perineural invasion in gastric cancer using spectral computed tomography imaging and machine learning.
Ge HT; Chen JW; Wang LL; Zou TX; Zheng B; Liu YF; Xue YJ; Lin WW
World J Gastroenterol; 2024 Feb; 30(6):542-555. PubMed ID: 38463023
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using
Jiang X; Li T; Wang J; Zhang Z; Chen X; Zhang J; Zhao X
Cancer Biother Radiopharm; 2024 Apr; 39(3):169-177. PubMed ID: 38193811
[No Abstract] [Full Text] [Related]
26. Quantitative Parameters of Diffusion Spectrum Imaging: HER2 Status Prediction in Patients With Breast Cancer.
Mao C; Jiang W; Huang J; Wang M; Yan X; Yang Z; Wang D; Zhang X; Shen J
Front Oncol; 2022; 12():817070. PubMed ID: 35186753
[TBL] [Abstract][Full Text] [Related]
27. Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?
Wang N; Wang X; Li W; Ye H; Bai H; Wu J; Chen M
Cancer Manag Res; 2020; 12():1211-1219. PubMed ID: 32110095
[TBL] [Abstract][Full Text] [Related]
28. Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer.
Mei Y; Wang S; Feng T; Yan M; Yuan F; Zhu Z; Li T; Zhu Z
Front Cell Dev Biol; 2021; 9():781824. PubMed ID: 35004681
[No Abstract] [Full Text] [Related]
29. Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer.
Shi HZ; Wang YN; Huang XH; Zhang KC; Xi HQ; Cui JX; Liu GX; Liang WT; Wei B; Chen L
World J Gastroenterol; 2017 Mar; 23(10):1836-1842. PubMed ID: 28348489
[TBL] [Abstract][Full Text] [Related]
30. Accurate preoperative staging and HER2 status prediction of gastric cancer by the deep learning system based on enhanced computed tomography.
Guan X; Lu N; Zhang J
Front Oncol; 2022; 12():950185. PubMed ID: 36452488
[TBL] [Abstract][Full Text] [Related]
31. Preoperative prediction of vessel invasion in locally advanced gastric cancer based on computed tomography radiomics and machine learning.
Hu ZW; Liang P; Li ZL; Yong LL; Lu H; Wang R; Gao JB
Oncol Lett; 2023 Jul; 26(1):293. PubMed ID: 37274479
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
Feng S; Yin J
Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
[TBL] [Abstract][Full Text] [Related]
33. Human epidermal growth factor 2 overexpressed alpha-fetoprotein-producing-gastric cancer.
Shimizu H; Kochi M; Fujii M; Watabe M; Matsuno Y; Kawai T; Suda H; Tanino T; Nakanishi Y; Masuda S; Okamura Y
Discov Oncol; 2023 Jun; 14(1):111. PubMed ID: 37354221
[TBL] [Abstract][Full Text] [Related]
34. Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment.
Yoon SH; Kim YH; Lee YJ; Park J; Kim JW; Lee HS; Kim B
PLoS One; 2016; 11(8):e0161278. PubMed ID: 27517841
[TBL] [Abstract][Full Text] [Related]
35. [Correlations of
Wang JL; Shi AQ; Fan CC; Wang YZ; Guo GR; Liu JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):628-635. PubMed ID: 36065696
[TBL] [Abstract][Full Text] [Related]
36. Amplification of the human epidermal growth factor receptor 2 (
Huang H; Wang Z; Li Y; Zhao Q; Niu Z
J Gastrointest Oncol; 2021 Apr; 12(2):377-387. PubMed ID: 34012633
[TBL] [Abstract][Full Text] [Related]
37. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study.
Deng Y; Lu Y; Li X; Zhu Y; Zhao Y; Ruan Z; Mei N; Yin B; Liu L
Eur Radiol; 2024 Jan; ():. PubMed ID: 38276982
[TBL] [Abstract][Full Text] [Related]
38. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.
Liu X; Xu P; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
Onco Targets Ther; 2016; 9():949-58. PubMed ID: 27013889
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer.
Seo KW; Jeon T; Kim S; Kim SS; Kim K; Suh BJ; Hwang S; Choi S; Ryu S; Min JS; Lee YJ; Jee YS; Chae H; Yang DH; Lee SH
J Gastric Cancer; 2017 Mar; 17(1):52-62. PubMed ID: 28337363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
